Skip to main content

exchange select nicotine

NDC 55301-734 · Army & Air Force Exchange Service

Generic nameNicotine Polacrilex
Dosage formLOZENGE
RouteORAL
Active ingredient(s)NICOTINE
Strength2 mg/1
Pharmacologic classCholinergic Nicotinic Agonist [EPC], Nicotine [CS]
Marketing categoryANDA

Packages

55301-734-60 — 1 VIAL in 1 CARTON (55301-734-60) / 20 LOZENGE in 1 VIAL

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

51316-319 — nicotine polacrilex, 51316-787 — nicotine polacrilex, 53329-191 — nicotine, 53329-192 — nicotine, 53329-193 — nicotine, 55301-428 — Nicotine Polacrilex, 55301-429 — Nicotine Polacrilex, 55301-503 — Nicotine Polacrilex, 55301-504 — Nicotine Polacrilex, 55301-617 — Nicotine Polacrilex, 55301-873 — Nicotine Polacrilex, 55301-957 — Nicotine Polacrilex, 55319-966 — Nicotine Polacrilex, 55741-001 — Nicotine Polacrilex, 55741-004 — Nicotine Polacrilex, 55741-446 — Nicotine Transdermal System Patch, 55741-447 — Nicotine Transdermal System Patch, 55741-448 — Nicotine Transdermal System Patch, 55910-122 — Nicotine Polacrilex, 55910-313 — Nicotine, +734 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels